Evidence map›Paper›PMID 36660874›Full record

ArticleHealth expectations : an international journal of public participation in health care and health policy2023

Development and early-stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient-driven approach.

Samantha Pollard, Deirdre Weymann, Rosalie Loewen, Jennifer Nuk, Sophie Sun, Kasmintan A Schrader, Chiquita Hessels, Dean A Regier

Open access · goldFull text read
In one paragraph

Article in Health expectations : an international journal of public participation in health care and health policy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Design and evaluation patient portal for patients with HTLV-1.BMC medical informatics and decision making · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Samantha PollardCancer Control Research, BC Cancer, Vancouver, British Columbia, Canada.ORCID 0000-0002-3070-2092
Deirdre WeymannCancer Control Research, BC Cancer, Vancouver, British Columbia, Canada.ORCID 0000-0002-3072-5657
Rosalie LoewenCancer Control Research, BC Cancer, Vancouver, British Columbia, Canada.
Jennifer NukHereditary Cancer Program, BC Cancer, Vancouver, British Columbia, Canada.
Sophie SunHereditary Cancer Program, BC Cancer, Vancouver, British Columbia, Canada.ORCID 0000-0001-6003-7786
Kasmintan A SchraderHereditary Cancer Program, BC Cancer, Vancouver, British Columbia, Canada.ORCID 0000-0002-7413-4314
Chiquita HesselsLi-Fraumeni Syndrome Association Canada, Vancouver, British Columbia, Canada.
Dean A RegierCancer Control Research, BC Cancer, Vancouver, British Columbia, Canada.ORCID 0000-0001-8876-0511
BC Cancer Agency · CACanadian Centre for Applied Research in Cancer Control · CAResearch Canada · CAUniversity of British Columbia · CA

Funding

CIHR PCG-155555
6 · The paper itself

Abstract

introductionGenetic testing for hereditary cancer syndromes (HCSs) can improve health outcomes through cancer risk mitigation strategies. Effective communication between tested individuals and their family members is key to reducing the hereditary cancer burden. Our objective was to develop a patient portal to improve familial communication for patients undergoing HCS genetic testing, followed by an early-phase evaluation.

methodsThe portal was developed following the completion of 25 semistructured interviews with individuals having undergone HCS susceptibility testing at BC Cancer. Following initial development, we recruited patients and healthcare providers to provide critical feedback informing portal refinement. Quantitative feedback was summarized using descriptive statistics, and qualitative feedback was synthesized by two reviewers who engaged in iterative discussion within the research team to prioritize recommendations for integration.

resultsThe patient portal includes four key components consisting of (a) targeted educational information about hereditary cancer and HBOC syndrome associated risks and testing process overview, (b) a general frequently asked questions 'FAQ' page informed by the qualitative interviews, patient partner feedback, and consultation with the HCP, (c) guidance to support familial communication including a video developed with a patient partner describing their lived experience navigating the communication process and (d) a series of lay summaries of genetic test findings to support information transfer among family members. Thirteen healthcare providers and seven patients participated in user testing. Domains within which participant recommendations were provided included presentation, educational content and process clarification.

conclusionsThis investigation demonstrates the value of continual integration of patient and provider preferences through the development of tools endeavouring to assist with complex genomics-informed decision-making. Our work aims to broaden the population-wide impact of HCS testing programs by improving communication processes between probands and their potentially affected family members. PATIENT OR PUBLIC CONTRIBUTION: This work involved a patient partner who was actively engaged in all aspects of the research investigation including protocol development, review and editing of all study documentation (including that of the previously published qualitative investigation), interpretation of results, as well as reviewing and editing the manuscript. Patient partners and healthcare professionals were recruited as research participants to provide critical feedback on the patient portal.

Indexed as

NeoplasmsPatient PortalsCommunicationGenetic Predisposition to DiseaseGenetic TestingHumansdecision makingfamilial cancergenetic testinghereditary cancer syndromespatient education

Identifiers

PMID36660874
PMCPMC10010078
OpenAlexW4317567169

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.